These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 16781760)
1. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus. Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760 [TBL] [Abstract][Full Text] [Related]
2. Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination. Ota MO; Ndhlovu Z; Oh S; Piyasirisilp S; Berzofsky JA; Moss WJ; Griffin DE J Infect Dis; 2007 Jun; 195(12):1799-807. PubMed ID: 17492596 [TBL] [Abstract][Full Text] [Related]
3. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses. Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781 [TBL] [Abstract][Full Text] [Related]
4. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins. Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946 [TBL] [Abstract][Full Text] [Related]
5. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies. Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037 [TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303 [TBL] [Abstract][Full Text] [Related]
7. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles. Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066 [TBL] [Abstract][Full Text] [Related]
8. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. Wild TF; Bernard A; Spehner D; Drillien R J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193 [TBL] [Abstract][Full Text] [Related]
9. Measles virus hemagglutinin induces an Ld-restricted CD8+ cytotoxic T lymphocyte response to two specific epitopes. Beauverger P; Buckland R; Wild F Virology; 1994 Apr; 200(1):281-3. PubMed ID: 7510439 [TBL] [Abstract][Full Text] [Related]
10. Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses. Didierlaurent A; Ramirez JC; Gherardi M; Zimmerli SC; Graf M; Orbea HA; Pantaleo G; Wagner R; Esteban M; Kraehenbuhl JP; Sirard JC Vaccine; 2004 Sep; 22(25-26):3395-403. PubMed ID: 15308364 [TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing human HLA and CD8 molecules generate HLA-restricted measles virus cytotoxic T lymphocytes of the same specificity as humans with natural measles virus infection. Tishon A; LaFace DM; Lewicki H; van Binnendijk RS; Osterhaus A; Oldstone MB Virology; 2000 Sep; 275(2):286-93. PubMed ID: 10998329 [TBL] [Abstract][Full Text] [Related]
12. Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection. Srivastava R; Khan AA; Garg S; Syed SA; Furness JN; Vahed H; Pham T; Yu HT; Nesburn AB; BenMohamed L J Virol; 2017 Jan; 91(2):. PubMed ID: 27847359 [TBL] [Abstract][Full Text] [Related]
13. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide. Partidos CD; Vohra P; Steward MW Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582 [TBL] [Abstract][Full Text] [Related]
14. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies. Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158 [TBL] [Abstract][Full Text] [Related]
15. Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse. Shao HY; Lin YW; Yu SL; Lin HY; Chitra E; Chang YC; Sia C; Chong P; Hsu MT; Wei OL; Chow YH PLoS One; 2011; 6(9):e25500. PubMed ID: 21980478 [TBL] [Abstract][Full Text] [Related]
16. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7. Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305 [TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus recombinants expressing either the measles virus fusion or hemagglutinin glycoprotein protect dogs against canine distemper virus challenge. Taylor J; Pincus S; Tartaglia J; Richardson C; Alkhatib G; Briedis D; Appel M; Norton E; Paoletti E J Virol; 1991 Aug; 65(8):4263-74. PubMed ID: 1830113 [TBL] [Abstract][Full Text] [Related]
18. Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model. Qi Y; Xing K; Zhang L; Zhao F; Yao M; Hu A; Wu X J Cancer Res Clin Oncol; 2018 Oct; 144(10):1945-1957. PubMed ID: 30090962 [TBL] [Abstract][Full Text] [Related]
19. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182 [TBL] [Abstract][Full Text] [Related]
20. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. Rodrigues M; Li S; Murata K; Rodriguez D; Rodriguez JR; Bacik I; Bennink JR; Yewdell JW; Garcia-Sastre A; Nussenzweig RS J Immunol; 1994 Nov; 153(10):4636-48. PubMed ID: 7525709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]